See also this year's filing and all EDGAR filings for this company.
PDF Report 0001404644_2022_Neoleukin_Therapeutics_Inc.pdf
Logs
| warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0001404644', 'EntityCommonStockSharesOutstanding': 42493971, 'Assets': 163263000, 'AssetsCurrent': 143989000, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 128000, 'Liabilities': 20399000, 'LiabilitiesAndStockholdersEquity': 163263000, 'LiabilitiesCurrent': 8636000, 'LiabilitiesNoncurrent': 11696000, 'NetIncome': -60692000, 'PropertyPlantAndEquipmentNet': 0, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 19146000, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 67000, 'remainder_LiabilitiesAndStockholdersEquity': 142864000, 'remainder_NetIncome': -60692000, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001404644')"} |
Edgar->Model Mapping
